Literature DB >> 31548136

Standardized Screening for Depression in Pediatric Epilepsy.

Erin Fecske, Paul Glasier, Lines M Vargas Collado, Elizabeth Rende.   

Abstract

INTRODUCTION: Depression is a common comorbidity of epilepsy that is under-recognized and under-diagnosed. To improve recognition, a brief screening tool, the Neurological Disorders Depression Inventory-Epilepsy-Youth (NDDI-E-Y) was implemented in a level-IV pediatric epilepsy clinic.
METHOD: This quality improvement is a pre-post design measuring the impact of standardized depression screening, via the NDDI-E-Y tool, in youth 12-17 years with epilepsy. Those with positive screens, scores > 32, received social work evaluation and mental health resources. Education was provided to all patients in standard discharge paperwork.
RESULTS: Of N = 176 patients evaluated, n = 112 met criteria to complete the NDDI-E-Y. Fifteen percent (n = 17) of patients had positive screens, suggesting that they are at risk for depression. DISCUSSION: Depression is a challenge when managing patients with epilepsy and may impact their quality of life and seizure control. Routine depression screening is recommended and feasible in the outpatient setting with a standardized work process.
Copyright © 2019 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epilepsy; depression; pediatric epilepsy; quality improvement

Mesh:

Year:  2019        PMID: 31548136     DOI: 10.1016/j.pedhc.2019.07.004

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  2 in total

1.  Prevalence of depression among epileptic patients in Taif City, Saudi Arabia.

Authors:  Adnan A Mubaraki; Afnan K Sibyani; Rehab A Alkhawtani; Bashaier G Alqahtani; Faris K Abu Alaynayn
Journal:  Neurosciences (Riyadh)       Date:  2021-10       Impact factor: 0.735

2.  Assessment of the Frequency of Depressive Symptoms in Epileptic Children (Single Center Study).

Authors:  Nageh Shehata; Salah Mahmoud Saleh; Ahmed M Kamal; Omnia Kamal Awad
Journal:  Risk Manag Healthc Policy       Date:  2021-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.